40 results
F-1/A
EX-1.1
APTO
Aptose Biosciences Inc
3 Jun 10
Registration statement (foreign) (amended)
12:00am
by the Placement Agents, (a) the costs incident to the authorization, issuance, sale, preparation and delivery of the Shares and Warrants to the Purchasers … and any stock or transfer taxes and stamp or similar duties payable in that connection; (b) the costs incident to the Registration of the Offered
6-K
EX-99.1
APTO
Aptose Biosciences Inc
5 Dec 18
Current report (foreign)
12:00am
their efficient use. Theft, carelessness and waste have a direct impact on the Company’s profitability. Any suspected incident of fraud or theft should … incident of fraud or theft should be immediately reported for investigation. The Company’s information technology system and other technology resources
10-Q
EX-10.1
zb1mwtamfhq17rw
7 May 19
Quarterly report
4:47pm
6-K
EX-99.1
ecmxld8e4wvf6zm1
31 May 18
Common Share Purchase Agreement
12:00pm
20-F/A
EX-4.7
tawcucf629vn8 lwlrtz
11 Jan 13
Annual report (foreign) (amended)
12:00am
8-K
EX-10.1
r38 bx8yk
5 May 20
Aptose Reports Results for the First Quarter 2020
5:01pm
8-K
EX-10.1
2nvdue3yesisgar8ob5
12 Dec 22
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
h6r1t2
24 May 19
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-1.1
dr3yjlkszgev
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
8-K
EX-10.2
kbrtvple 2541wmyo
26 May 23
Entry into a Material Definitive Agreement
4:01pm
424B3
txdsj5cgn8md
6 Jul 23
Prospectus supplement
4:01pm
424B5
146cdlj ahzub
3 May 19
Prospectus supplement for primary offering
1:56pm
424B5
pywz0yjf
13 May 19
Prospectus supplement for primary offering
12:00am